The New Normal for Clinical Trials and Planning for the Future

Tuesday, October 6, 2020
8am PDT/11 am EDT/4pm BST

Presented by Dr. Theodore Search, Skipta CEO; and Loni Branon, Senior Director for Citeline

Our panel of industry experts will discuss the impact of COVID-19 on clinical trials, the new normal and key considerations for future planning –  Register now to be part of this important session to help you get ahead

What you’ll hear
  • How has COVID-19 impacted clinical trials?
  • What barriers still exist?
  • What do investigators, patients, and industry need in order to continue making progress in trials?
  • Have investigators seen an increase in the diversity of participants?
  • How quickly and successfully has industry pivoted to decentralized/hybrid design trials?


Dr. Theodore Search
CEO, Skipta
Dr. Theodore Search, Pharm. D. is an innovation advocate, entrepreneur, tech guru, and expert in healthcare. He has been invited to speak at various healthcare and technology conferences around the world and named amongst the Top 100 Most Inspiring People in the Life Sciences Industry in 2015 and amongst the Top 100 Elite Entrepreneurs in the pharmaceutical and healthcare industry in 2016.

Dr. Search founded Skipta, a verified social network for physicians and medical professionals in 2008 and grew the company to over 1 million physician members.  In 2017, Skipta became part of Informa Pharma Intelligence, and Dr. Search is the CEO of Skipta-Informa, and serves on the senior leadership group for Informa Pharma Intelligence.

Loni Branon
Senior Director, Sitetrove, Citeline Engage, and Strategic Partnerships
Loni Branon is Senior Director of Citeline’s Sitetrove, the pharma industry’s most comprehensive clinical investigator and trial site intelligence solution, and Citeline Engage, which combines the industry’s most comprehensive clinical trial intelligence suite with the leading online community of verified healthcare professionals (HCPs) powered by Skipta.

Loni oversees data content and analyst support services and works closely with clients on solving their site feasibility challenges by developing strategies to optimize country level decisions and identifying the best, most experienced clinical investigators and trial sites for their clinical programs.